AU2009313999B2 - Autism associated genetic markers - Google Patents

Autism associated genetic markers

Info

Publication number
AU2009313999B2
AU2009313999B2 AU2009313999A AU2009313999A AU2009313999B2 AU 2009313999 B2 AU2009313999 B2 AU 2009313999B2 AU 2009313999 A AU2009313999 A AU 2009313999A AU 2009313999 A AU2009313999 A AU 2009313999A AU 2009313999 B2 AU2009313999 B2 AU 2009313999B2
Authority
AU
Australia
Prior art keywords
chr7
chr2
chm
chr20
chr14
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009313999A
Other languages
English (en)
Other versions
AU2009313999A1 (en
Inventor
Mark F. Leppert
Alex S. Lindell
Nori Matsunami
William M. McMahon
Michael S. Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation UURF
Lineagen Inc
Original Assignee
University of Utah Research Foundation UURF
Lineagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation UURF, Lineagen Inc filed Critical University of Utah Research Foundation UURF
Publication of AU2009313999A1 publication Critical patent/AU2009313999A1/en
Application granted granted Critical
Publication of AU2009313999B2 publication Critical patent/AU2009313999B2/en
Priority to AU2016277753A priority Critical patent/AU2016277753A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2009313999A 2008-11-12 2009-11-12 Autism associated genetic markers Ceased AU2009313999B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2016277753A AU2016277753A1 (en) 2008-11-12 2016-12-23 Autism associated genetic markers

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11396308P 2008-11-12 2008-11-12
US61/113,963 2008-11-12
PCT/US2009/064252 WO2010056897A1 (fr) 2008-11-12 2009-11-12 Marqueurs génétiques associés à l’autisme

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016277753A Division AU2016277753A1 (en) 2008-11-12 2016-12-23 Autism associated genetic markers

Publications (2)

Publication Number Publication Date
AU2009313999A1 AU2009313999A1 (en) 2010-05-20
AU2009313999B2 true AU2009313999B2 (en) 2016-09-29

Family

ID=42170337

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2009313999A Ceased AU2009313999B2 (en) 2008-11-12 2009-11-12 Autism associated genetic markers
AU2016277753A Abandoned AU2016277753A1 (en) 2008-11-12 2016-12-23 Autism associated genetic markers

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2016277753A Abandoned AU2016277753A1 (en) 2008-11-12 2016-12-23 Autism associated genetic markers

Country Status (6)

Country Link
US (5) US20100210471A1 (fr)
EP (2) EP2963129A3 (fr)
JP (2) JP5881420B2 (fr)
AU (2) AU2009313999B2 (fr)
CA (1) CA2743542A1 (fr)
WO (1) WO2010056897A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7702468B2 (en) 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
DK2601609T3 (en) 2010-08-02 2017-06-06 Population Bio Inc COMPOSITIONS AND METHODS FOR DISCOVERING MUTATIONS CAUSING GENETIC DISORDERS
US20140298494A1 (en) * 2011-07-25 2014-10-02 Beth Israel Deaconess Medical Center, Inc. Animal model of autism
EP2756313A4 (fr) * 2011-09-14 2015-04-22 Jackson H M Found Military Med Procédés et trousses permettant la détection et la surveillance de biomarqueurs de diagnostic pour le trouble de stress post-traumatique (tspt) et permettant de distinguer la forme suicidaire et la forme non suicidaire du trouble
WO2013054200A2 (fr) 2011-10-10 2013-04-18 The Hospital For Sick Children Méthodes et compositions de dépistage et de traitement de troubles du développement
US11180807B2 (en) 2011-11-04 2021-11-23 Population Bio, Inc. Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
US10407724B2 (en) 2012-02-09 2019-09-10 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
WO2014043519A1 (fr) 2012-09-14 2014-03-20 Population Diagnostics Inc. Procédés et compositions pour le diagnostic, le pronostic et le traitement d'états neurologiques
WO2014052855A1 (fr) 2012-09-27 2014-04-03 Population Diagnostics, Inc. Procédés et compositions de dépistage et de traitement de troubles du développement
CA2934272A1 (fr) * 2013-12-20 2015-06-25 Lineagen, Inc. Diagnostic et prediction du trouble du spectre autistique
WO2016036403A1 (fr) 2014-09-05 2016-03-10 Population Diagnostics Inc. Méthodes et compositions destinées à inhiber et à traiter des états neurologiques
WO2018025856A1 (fr) * 2016-08-02 2018-02-08 学校法人武庫川学院 Procédé de dépistage génétique simple, procédé de mesure du nombre de copies, et technologie de support associée
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
US20210277476A1 (en) * 2018-07-12 2021-09-09 The Regents Of The University Of California Expression-Based Diagnosis, Prognosis and Treatment of Complex Diseases
SI3625368T1 (sl) 2018-08-08 2023-04-28 Pml Screening, Llc Postopki z genetskim testiranjem za oceno tveganja za razvoj progresivne multifokalne levkoencefalopatije, ki jo povzroča virus John Cunningham

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721098A (en) 1986-01-16 1998-02-24 The Regents Of The University Of California Comparative genomic hybridization
US5965362A (en) 1992-03-04 1999-10-12 The Regents Of The University Of California Comparative genomic hybridization (CGH)
EP1134293A3 (fr) * 1992-03-04 2004-01-07 The Regents of The University of California Hybridation génomique comparative
WO2003052086A1 (fr) * 2001-12-14 2003-06-26 President And Fellows Of Harvard College Recepteurs neuronaux relatifs a l'immunite et utilisation therapeutique
AU2003273640A1 (en) * 2002-10-10 2004-05-04 K.U. Leuven Research And Development Autism gene
ES2354238T3 (es) * 2003-07-03 2011-03-11 University Of Medicine And Dentistry Of New Jersey Genes como herramienta de diagnóstico para autismo.
DE602004021186D1 (de) * 2003-08-22 2009-07-02 Integragen Sa Menschliches autismus-suszeptibilitätsgen und verwendungen davon
US20050209181A1 (en) * 2003-11-05 2005-09-22 Huda Akil Compositions and methods for diagnosing and treating mental disorders
DE602004030372D1 (de) * 2003-12-05 2011-01-13 Beatrice And Samuel A Seaver Foundation Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
WO2005067603A2 (fr) * 2004-01-07 2005-07-28 Parallele Bioscience, Inc. Polymorphismes lies a l'autisme et leur usage
WO2006002262A2 (fr) * 2004-06-21 2006-01-05 The Board Of Trustees Of The Leland Stanford Junior University Genes et voies exprimes de maniere differentielle dans des troubles bipolaires et/ou troubles depressifs majeurs
WO2006003520A2 (fr) * 2004-07-01 2006-01-12 Integragen Gene de predisposition a l'autisme humain codant pour un facteur de transcription et ses utilisations
US9783851B2 (en) * 2008-02-20 2017-10-10 The Children's Hospital Of Philadelphia Genetic alterations associated with autism and the autistic phenotype and methods of use thereof for the diagnosis and treatment of autism
CA2766246C (fr) * 2008-11-14 2020-03-10 Hakon Hakonarson Variants genetiques intervenant dans la cognition humaine et leurs procedes d'utilisation comme cibles diagnostiques et therapeutiques

Also Published As

Publication number Publication date
US20210054457A1 (en) 2021-02-25
EP2358907A1 (fr) 2011-08-24
CA2743542A1 (fr) 2010-05-20
WO2010056897A1 (fr) 2010-05-20
EP2358907A4 (fr) 2012-06-06
EP2963129A2 (fr) 2016-01-06
JP2016039799A (ja) 2016-03-24
AU2016277753A1 (en) 2017-02-02
AU2009313999A1 (en) 2010-05-20
US20210222245A1 (en) 2021-07-22
JP2012508579A (ja) 2012-04-12
EP2963129A3 (fr) 2016-05-11
JP5881420B2 (ja) 2016-03-09
EP2358907B1 (fr) 2015-05-20
US20170166966A1 (en) 2017-06-15
US20100210471A1 (en) 2010-08-19
US20150148251A1 (en) 2015-05-28

Similar Documents

Publication Publication Date Title
US20210222245A1 (en) Autism associated genetic markers
Portales-Casamar et al. DNA methylation signature of human fetal alcohol spectrum disorder
Hakonarson et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene
US7914990B2 (en) Methods and products for in vitro genotyping
Maestrini et al. High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L–DOCK4 gene region in autism susceptibility
Li et al. Replication of TCF4 through association and linkage studies in late-onset Fuchs endothelial corneal dystrophy
US20100184044A1 (en) Detecting Genetic Abnormalities
Alvarez-Mora et al. Comprehensive molecular testing in patients with high functioning autism spectrum disorder
EP2061910B1 (fr) Méthode de pronostic
US20210024999A1 (en) Method of identifying risk for autism
Bens et al. Phenotypic spectrum and extent of DNA methylation defects associated with multilocus imprinting disturbances
Lebet et al. Mutations causing severe combined immunodeficiency: detection with a custom resequencing microarray
EP3740589A1 (fr) Biomarqueurs basés sur la méthylation de l'adn et l'âge phénotypique pour l'espérance de vie et la morbidité
CN115873947A (zh) 一种鼻咽癌遗传风险评估系统
WO2012173809A2 (fr) Procédé d'identification de variantes du nombre de nouvelles copies (cnv) à l'aide de jumeaux mz discordants pour des problèmes/troubles de l'attention
Schultz et al. Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis
Neela et al. Association of single nucleotide polymorphisms on locus 18q21. 1 in the etiology of nonsyndromic cleft lip palate (NSCLP) in Indian multiplex families
WO2008010082A2 (fr) Méthode diagnostique
JP2006296270A (ja) Ｐｒｋａａ２遺伝子多型による２型糖尿病発症素因の検出方法
Xu et al. A pooling genome-wide association study identifies susceptibility loci and signaling pathways of immune thrombocytopenia in Chinese Han population
Ma et al. Effect of uniparental disomy in parentage testing
Winchester et al. Detection, breakpoint identification and detailed characterisation of a CNV at the FRA16D site using SNP assays
Brynedal On genetics and transcriptomics of multiple sclerosis
Garg et al. A survey of rare epigenetic variation in 23,116 human genomes identifies disease-relevant epivariations and novel CGG expansions

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 12 NOV 2013 TO 12 JUN 2014 IN WHICH TO PAY A CONTINUATION FEE HAS BEEN FILED .

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A CONTINUATION FEE HAS BEEN EXTENDED TO 12 JUN 2014 .

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired